ClinicalTrials.gg
CompletedNCT01076933SiMaT-BUpdated May 11, 2017

Transcranial Magnetic Stimulation for Borderline Personality Disorder

An interventional study of repetitive Transcranial Stimulation Magnetic (rTMS) and sham rTMS in Borderline Personality Disorder, sponsored by University Hospital, Toulouse. Completed at 1 site in France. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2017-05-11.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Primary purpose : to assess the effect on neuropsychological tasks related to planning of 10 daily sessions of right dorsolateral prefrontal cortex with High-frequency repetitive transcranial magnetic stimulation (rTMS) on borderline personality disorder (BPD) patients.

Hypothesis : BPD patients receiving 10 sessions of rTMS will have greater improvement in the average number of move to achieve tasks of the Tower of London, than those receiving sham rTMS.

02

Conditions studied

  • Borderline Personality Disorder

Keywords

  • Borderline Personality Disorder
  • Transcranial Magnetic Stimulation
  • Neuropsychological Test
  • Randomised Control Trial
03

In context

Borderline Personality Disorder

277 studies on the registry are indexed under Borderline Personality Disorder; 68 are open to participants now.

This study's enrollment of 13 is below the median of 70 across 222 interventional studies indexed under Borderline Personality Disorder.

Browse Borderline Personality Disorder studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 805 studies on the registry; 215 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 20 to 45 years old
  • Borderline Personality Disorder (Diagnostic Interview for Borderline Personality Disorder > 8)
  • psychiatric follow-up
  • righthander
  • informed consent
  • affiliated to medical insurance

Exclusion criteria

Exclusion Criteria:

  • bipolar disorder
  • substance use disorder
  • Major Depressive Disorder or Stress Post Traumatic Disorder
  • history of epilepsy
  • neurosurgery
  • cardiac pacemaker
  • lefthander
  • involuntary admission
  • participation in an other research
  • legal guardianship
  • poor mastery of french.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    rTMS

    rTMS sessions

    Procedure: repetitive Transcranial Stimulation Magnetic (rTMS)

  • Sham comparator
    control

    sham rTMS (control)

    Procedure: sham rTMS

Interventions

  • Procedurerepetitive Transcranial Stimulation Magnetic (rTMS)

    The motor threshold was determined in each subject once, before treatment. This was defined as the lowest stimulation intensity capable of inducing a visible movement at least five times out of 10 stimulations. The position of the right dorsolateral prefrontal cortex was defined as 5 cm anterior (in a parasagittal line) to the motor cortex. The stimulus intensity was 80% of the patient's motor threshold intensity. Treatments were given for 20 minutes per day over 10 working days.

  • Proceduresham rTMS

    sham rTMS

06

What researchers measure

Primary outcomes

  1. Tower of London

    Time frame: Inclusion, 15th day, 30th day and 3rd month

Secondary outcomes

  1. Balloon Analog Risk Task

    Time frame: Inclusion, 15th day, 30th day and 3rd month

  2. Micro-World Test

    Time frame: Inclusion, 15th day and 3rd month

  3. Borderline Personality Disorder Severity Index

    Time frame: Pre-inclusion, 30th day and 3rd month

  4. Symptom Check List - 90

    Time frame: Inclusion, 15th day, 30th day and 3rd month

  5. Barratt Impulsivity Scale

    Time frame: Inclusion and 3rd month

  6. Global Assessment Scale

    Time frame: Inclusion and 3rd month

07

Study locations

1 site
  • Lionel Cailhol
    Toulouse, University Hospital Toulouse 31059, France
08

References and documents

Publications

  • Cailhol L, Roussignol B, Klein R, Bousquet B, Simonetta-Moreau M, Schmitt L, Thalamas C, Tap G, Birmes P. Borderline personality disorder and rTMS: a pilot trial. Psychiatry Res. 2014 Apr 30;216(1):155-7. doi: 10.1016/j.psychres.2014.01.030. Epub 2014 Jan 30. PubMed 24503285 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01076933
Responsible party
Sponsor
First posted
Feb 26, 2010
Start date
Jan 2010
Primary completion
Mar 2011
Completion
Apr 2012
Last update
May 11, 2017

Study contacts

Lionel Cailhol, MD
principal investigator · University Hospital Toulouse - 31059 Toulouse - France

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion